Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Julie Christine Lauffenburger, Ph.D., Pharm.D.

Concepts (245)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medication Adherence32202421764.560 Why?
Prescription Drugs520236311.680 Why?
Inappropriate Prescribing420242111.660 Why?
Pharmaceutical Services620211411.530 Why?
Pharmacy22022911.410 Why?
Hypoglycemic Agents10202430811.350 Why?
Hypertension16202485421.330 Why?
Insurance, Pharmaceutical Services420233481.300 Why?
Chronic Disease11202193201.070 Why?
Diabetes Mellitus, Type 292023121430.890 Why?
Health Expenditures6202323660.880 Why?
Antidepressive Agents, Tricyclic120244320.790 Why?
Electronic Prescribing120211140.710 Why?
Touch Perception120211070.710 Why?
Antihypertensive Agents8202420230.690 Why?
Pharmacies220211690.680 Why?
Pharmacists420192600.680 Why?
Reinforcement, Social12018100.650 Why?
Anticoagulants6202448130.630 Why?
Gout220236210.620 Why?
Cardiovascular Agents320198400.610 Why?
Medicare12202467700.600 Why?
Nurse Practitioners120212710.590 Why?
Glycemic Index120203960.570 Why?
Patient-Centered Care2201714220.550 Why?
Uric Acid120238070.540 Why?
Warfarin3202414830.540 Why?
Cardiovascular Diseases72023154980.530 Why?
Insulin3202066020.530 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors5202332440.520 Why?
Drug Prescriptions3202416690.520 Why?
Metformin120239060.510 Why?
Complementary Therapies120204860.510 Why?
United States322024723390.510 Why?
Health Care Costs2202032430.500 Why?
Fee-for-Service Plans120207000.500 Why?
Medical Informatics120227320.500 Why?
Medication Therapy Management220171300.500 Why?
Community Pharmacy Services22012520.490 Why?
Atrial Fibrillation5202451270.490 Why?
Retrospective Studies282024805820.490 Why?
Vaccines120238370.480 Why?
Communication4202238710.470 Why?
Cost Control120176280.460 Why?
Health Services Needs and Demand1202214030.460 Why?
Humans8220247614230.460 Why?
Shock, Septic120207680.460 Why?
Diabetes Complications1202013150.440 Why?
Medicare Part D220193550.430 Why?
Female5420243925810.430 Why?
Primary Health Care6202446860.410 Why?
Polypharmacy320213050.400 Why?
Social Support1202221720.400 Why?
Male4620243607360.390 Why?
Antidepressive Agents1202428970.390 Why?
Aged3420241692350.390 Why?
Adrenal Cortex Hormones1202018760.390 Why?
Analgesics, Opioid3202338040.380 Why?
Diabetes Mellitus7202158400.380 Why?
Life Change Events120169520.370 Why?
Middle Aged3320242208260.370 Why?
Formularies as Topic12011940.360 Why?
Databases, Factual4201679560.360 Why?
Electronic Health Records4202448110.340 Why?
Prescriptions220233860.340 Why?
Self Report4202337240.340 Why?
Hyperlipidemias420187710.340 Why?
Pharmacoepidemiology120133500.330 Why?
Patient Participation2202414440.330 Why?
Patient Compliance1201926900.310 Why?
Drugs, Generic120134480.300 Why?
Gastrointestinal Hemorrhage1201511160.300 Why?
Family1201831970.290 Why?
Telephone220226270.290 Why?
Heart Failure42024116740.280 Why?
Sepsis1202025850.270 Why?
Health Behavior1201826410.270 Why?
Hepatitis C, Chronic1201410320.260 Why?
Telemedicine2202130510.260 Why?
Decision Making2202239290.260 Why?
Insurance Claim Review320207410.260 Why?
Thrombolytic Therapy1201520650.260 Why?
Internship and Residency2202458790.250 Why?
Drug Costs2202311830.250 Why?
Blood Pressure6202384870.240 Why?
Long-Term Care220206330.240 Why?
Adult2420242211480.230 Why?
Insurance, Health1201724970.230 Why?
Physicians1202245910.230 Why?
Cholinergic Antagonists120241680.210 Why?
Atherosclerosis3202334070.200 Why?
Cohort Studies92023414460.200 Why?
Administration, Oral4202440160.200 Why?
Antiviral Agents1201430570.200 Why?
Aged, 80 and over112024589560.200 Why?
Risk Assessment52024239900.190 Why?
Blood Pressure Determination220226340.190 Why?
Brain Ischemia1201530490.190 Why?
Patient Care220206210.190 Why?
Qualitative Research2202230230.190 Why?
Gout Suppressants120231770.190 Why?
Tranexamic Acid120231760.190 Why?
Antifibrinolytic Agents120232920.180 Why?
Blood Glucose3202063910.170 Why?
Electronics120213170.170 Why?
Medical Staff, Hospital120246010.170 Why?
Insurance Carriers120211560.170 Why?
Logistic Models42019132550.170 Why?
New Jersey120202950.170 Why?
Behavior Control12019470.160 Why?
Vaccination2202333810.160 Why?
Myocardial Infarction32015114580.160 Why?
Technology120212920.160 Why?
Postal Service12018960.150 Why?
Drugs, Investigational220182120.150 Why?
Benzodiazepines1202411320.150 Why?
Medicare Part B120191170.150 Why?
Public Health1201126660.150 Why?
Secondary Prevention1202414740.150 Why?
Remote Consultation120202370.150 Why?
Frail Elderly120237630.150 Why?
Policy120215080.140 Why?
Adenosine Diphosphate120184220.140 Why?
Risk Factors92023741670.140 Why?
Hypnotics and Sedatives1202411790.130 Why?
Angiotensin Receptor Antagonists1202210390.130 Why?
Minority Groups1202312030.130 Why?
Cost Sharing120194090.120 Why?
Reminder Systems120183880.120 Why?
Biotransformation120141660.120 Why?
Cross-Sectional Studies32024261120.120 Why?
Comorbidity32020104980.120 Why?
Cytochrome P-450 CYP3A120141140.120 Why?
Small-Area Analysis12014550.120 Why?
Randomized Controlled Trials as Topic22021102030.120 Why?
Follow-Up Studies42020391170.110 Why?
Drug Approval220188140.110 Why?
Drug Utilization Review120142480.110 Why?
Clinical Trials, Phase III as Topic120168570.100 Why?
Prevalence32021157170.100 Why?
Education, Pharmacy12012380.100 Why?
Angiotensin-Converting Enzyme Inhibitors2202215170.100 Why?
Referral and Consultation2202236000.100 Why?
Patient Care Planning120179080.100 Why?
Income1202018760.100 Why?
Odds Ratio1202496450.100 Why?
International Normalized Ratio120133820.090 Why?
Platelet Aggregation Inhibitors2202427510.090 Why?
Adaptation, Psychological1202126320.090 Why?
Regression Analysis2201863430.090 Why?
Treatment Failure1201626420.090 Why?
Propensity Score2201519080.090 Why?
Cross-Over Studies1201620760.090 Why?
Malawi120113040.090 Why?
Drug Interactions1201414140.090 Why?
Health Status Disparities1202118520.080 Why?
Research Design3202161780.080 Why?
Publishing120168330.080 Why?
Socioeconomic Factors2202078250.080 Why?
Sex Distribution1201322810.080 Why?
Cesarean Section1201713960.080 Why?
Comparative Effectiveness Research120137090.080 Why?
Public Policy120125590.080 Why?
Survival Analysis12020100890.070 Why?
Adrenergic beta-Antagonists1201312410.070 Why?
Registries1202482230.070 Why?
Age Distribution1201328800.070 Why?
Drug Utilization1201311880.070 Why?
Cost-Benefit Analysis1202054920.070 Why?
Influenza, Human1201815210.070 Why?
Intensive Care Units1202037440.070 Why?
Prognosis22020296200.070 Why?
Treatment Outcome42024646510.070 Why?
Decision Support Techniques1201719980.070 Why?
Health Personnel1202133350.070 Why?
Hypolipidemic Agents220246090.070 Why?
Drug Monitoring120139620.070 Why?
Chi-Square Distribution1201334180.070 Why?
Pain, Postoperative1201717370.070 Why?
Drug Therapy, Combination1201763090.070 Why?
Intention to Treat Analysis220184130.070 Why?
Young Adult42021592070.070 Why?
Bone Density Conservation Agents120137950.070 Why?
Delivery of Health Care2202253350.070 Why?
Reimbursement Mechanisms120126670.070 Why?
Focus Groups1201214130.070 Why?
Sensitivity and Specificity12020146640.060 Why?
Evidence-Based Medicine2201436870.060 Why?
Combined Modality Therapy1201785290.060 Why?
Adolescent42021883130.060 Why?
Opioid-Related Disorders1201921620.060 Why?
Sex Factors22015105480.060 Why?
Transcription Factors12024121250.060 Why?
Hospitalization12024107180.060 Why?
Osteoporosis1201316050.060 Why?
Residence Characteristics1201420920.060 Why?
Disease Progression12020135020.050 Why?
Linear Models1201358690.050 Why?
Hemoptysis120231520.050 Why?
Denmark120247710.050 Why?
Digoxin120222460.050 Why?
Time Factors22024399750.050 Why?
Habits120211470.050 Why?
Ambulatory Care1201227750.050 Why?
Administration, Inhalation1202311560.040 Why?
Longitudinal Studies12017145990.040 Why?
Glucagon-Like Peptide 1120233640.040 Why?
Age Factors32024184000.040 Why?
Pyridones120248090.040 Why?
Behavioral Sciences12018290.040 Why?
Stroke2202497560.040 Why?
Biphenyl Compounds1202210070.040 Why?
Thiazoles1202415170.040 Why?
Early Termination of Clinical Trials12016690.030 Why?
Quality of Health Care1201243300.030 Why?
Patient Acceptance of Health Care2202232040.030 Why?
Tetrazoles120229090.030 Why?
Deductibles and Coinsurance120183160.030 Why?
Drug Combinations1202220480.030 Why?
Immunization Programs120182680.030 Why?
Antineoplastic Agents12018136370.030 Why?
Evidence-Based Practice120184950.030 Why?
Pyrazoles1202420070.030 Why?
Students, Pharmacy12012170.030 Why?
Pyridines1202428750.030 Why?
Safety1201611500.020 Why?
Injections120138300.020 Why?
Obstetrics120176650.020 Why?
Health Knowledge, Attitudes, Practice1202440140.020 Why?
Professional Role120123140.020 Why?
United States Food and Drug Administration1201816640.020 Why?
Social Class1201820040.020 Why?
Faculty120123830.020 Why?
Neoplasms12018221640.020 Why?
Healthcare Disparities1202433570.020 Why?
Stroke Volume1202254970.020 Why?
Advisory Committees120127860.020 Why?
Patient Selection1201942440.020 Why?
Risk1201896120.020 Why?
Medicaid1201928180.020 Why?
Periodicals as Topic1201614630.020 Why?
Teaching1201211690.010 Why?
Exercise1201958840.010 Why?
Prospective Studies22018544150.010 Why?
Pregnancy12017298620.010 Why?
Lauffenburger's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (245)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.